# CERTIFICATE OF
AMENDMENT OF CERTIFICATE OF INCORPORATION
OFVIRAL GENETICS, INC.

Viral
 Genetics,  Inc., a corporation  organized  and existing  under the General  Corporation
 Law of  the State of Delaware (the Corporation) does hereby certify that:

The
amendment to the Corporations Certificate of Incorporation set forth below was duly
adopted by resolutions approved by the Corporations Board of Directors and
stockholders in accordance with the provisions of Section 242 of the General Corporation
Law of the State of Delaware. The amendments will be effective as of 12:01 am Eastern Time
on November 17, 2004.

Amendment No. 1.  The Certificate
of Incorporation of the corporation is amended by striking article FOURTH in its
entirety and replacing there for:

| | FOURTH.       
               The total number of shares of all classes of capital stock that the corporation
               shall have authority to issue is 270,000,000 shares. Stockholders shall not have
               any preemptive rights, nor shall stockholders have the right to cumulative
               voting in the election of directors or for any other purpose. The classes and
               the aggregate number of shares of stock of each class that the corporation shall
               have authority to issue are as follows:
| | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | (a)       
               250,000,000 shares of Common Stock, $0.0001 par value (Common
               Stock).
| | ----------------------------------------------------------------------------------------------------------------

| | (b)       
               20,000,000 shares of Preferred Stock, $0.0001 par value (Preferred
               Stock).
| | ---------------------------------------------------------------------------------------------------------------------

| | The
Preferred Stock may be issued from time to time in one or more series, with such
distinctive serial designations as may be stated or expressed in the resolution or
resolutions providing for the issue of such stock adopted from time to time by the Board
of Directors; and in such resolution or resolutions providing for the issuance of shares
of each particular series, the Board of Directors is also expressly authorized to fix: the
right to vote, if any; the consideration for which the shares of such series are to be
issued; the number of shares constituting such series, which number may be increased
(except as otherwise fixed by the Board of Directors) or decreased (but not below the
number of shares thereof then outstanding) from time to time by action of the Board of
Directors; the rate of dividends upon which and the times at which dividends on shares of
such series shall be payable and the preference, if any, which such dividends shall have
relative to dividends on shares of any other class or classes or any other series of stock
of the corporation; whether such dividends shall be cumulative or noncumulative, and if
cumulative, the date or dates from which dividends on shares of such series shall be
cumulative; the rights, if any, which the holders of shares of such series shall have in
the event of any voluntary or involuntary liquidation, merger, consolidation, distribution
or sale of assets, dissolution or winding up of the affairs of the corporation; the
rights, if any, which the holders of shares of such series shall have to convert such
shares into or exchange such shares for shares of any other class or classes or any other
series of stock of the Corporation or for any debt securities of the corporation and the
terms and conditions, including price and rate of exchange, of such conversion or
exchange; whether shares of such series shall be subject to redemption, and the redemption
price or prices and other terms of redemption, if any, for shares of such series
including, without limitation, a redemption price or prices payable in shares of Common
Stock; the terms and amounts of any sinking fund for the purchase or redemption of shares
of such series; and any and all other designations, preferences, and relative,
participating, optional or other special rights, qualifications, limitations or
restrictions thereof pertaining to shares of such series permitted by law.
| | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IN
WITNESS WHEREOF, Viral Genetics, Inc., has caused this Certificate to be signed by its
duly authorized officer this 1st day of November 2004.

| |                     
| | --------------------
| | VIRAL GENETICS, INC.
| |                     

| |  |     |  |                           | 
| |  | --- |  | ------------------------- | 
| |  | By: |  | /s/ Haig Keledjian        | 
| |  |     |  | Haig Keledjian, President | 

2